human alpha-1-proteinase inhibitor

Poland

Drugs containing this active substance

  • PROLASTIN

    The medicine is used for long-term supportive treatment in individuals with alpha-1 antitrypsin deficiency. It aims to restore balance in the lungs and prevent further progression of pulmonary emphysema.

    Form: powder and solvent for preparation of infusion solution

    Active substance Dosage
    human alpha-1-proteinase inhibitor 4000 mg

    ATC: B02AB02

    Manufacturer: Instituto Grifols, S.A.

  • PROLASTIN

    It is used for long-term adjunctive treatment in individuals with alpha-1-proteinase inhibitor deficiency. It aims to restore balance in the lungs and prevent further progression of pulmonary emphysema.

    Form: powder and solvent for preparation of infusion solution

    Active substance Dosage
    human alpha-1-proteinase inhibitor 5000 mg

    ATC: B02AB02

    Manufacturer: Instituto Grifols, S.A.